GR3020612T3 - 1-(Pyrido[3,4-b]-1,4-oxazinyl-4-yl)-1H-indoles, intermediates and a process for their preparation, and their use as medicaments - Google Patents

1-(Pyrido[3,4-b]-1,4-oxazinyl-4-yl)-1H-indoles, intermediates and a process for their preparation, and their use as medicaments

Info

Publication number
GR3020612T3
GR3020612T3 GR960401978T GR960401978T GR3020612T3 GR 3020612 T3 GR3020612 T3 GR 3020612T3 GR 960401978 T GR960401978 T GR 960401978T GR 960401978 T GR960401978 T GR 960401978T GR 3020612 T3 GR3020612 T3 GR 3020612T3
Authority
GR
Greece
Prior art keywords
loweralkyl
hydrogen
medicaments
chem
oxazinyl
Prior art date
Application number
GR960401978T
Other languages
English (en)
Inventor
Richard Charles Effland
Larry Davis
Gordon Edward Olsen
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of GR3020612T3 publication Critical patent/GR3020612T3/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
GR960401978T 1991-04-15 1996-07-24 1-(Pyrido[3,4-b]-1,4-oxazinyl-4-yl)-1H-indoles, intermediates and a process for their preparation, and their use as medicaments GR3020612T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/684,758 US5214038A (en) 1991-04-15 1991-04-15 1-(pyrido[3,4-b]-1,4-oxazinyl-4-yl)-1H-indoles and intermediates for the preparation thereof

Publications (1)

Publication Number Publication Date
GR3020612T3 true GR3020612T3 (en) 1996-10-31

Family

ID=24749434

Family Applications (1)

Application Number Title Priority Date Filing Date
GR960401978T GR3020612T3 (en) 1991-04-15 1996-07-24 1-(Pyrido[3,4-b]-1,4-oxazinyl-4-yl)-1H-indoles, intermediates and a process for their preparation, and their use as medicaments

Country Status (22)

Country Link
US (3) US5214038A (el)
EP (1) EP0509400B1 (el)
JP (1) JP2608359B2 (el)
KR (1) KR100201509B1 (el)
AT (1) ATE140006T1 (el)
AU (1) AU643135B2 (el)
CA (1) CA2065986C (el)
CZ (1) CZ282054B6 (el)
DE (1) DE69211892T2 (el)
DK (1) DK0509400T3 (el)
ES (1) ES2094840T3 (el)
FI (1) FI97544C (el)
GR (1) GR3020612T3 (el)
HU (1) HUT62588A (el)
IE (1) IE74907B1 (el)
IL (1) IL101589A (el)
NO (1) NO301765B1 (el)
NZ (2) NZ242309A (el)
PL (1) PL168671B1 (el)
RU (1) RU2042680C1 (el)
TW (1) TW211016B (el)
ZA (1) ZA922721B (el)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5360811A (en) * 1990-03-13 1994-11-01 Hoechst-Roussel Pharmaceuticals Incorporated 1-alkyl-, 1-alkenyl-, and 1-alkynylaryl-2-amino-1,3-propanediols and related compounds as anti-inflammatory agents
US5264442A (en) * 1990-08-13 1993-11-23 Hoechst-Roussel Pharmaceuticals Incorporated Carbamoyl-1-(pyridinylalkyl)-1H-indoles, indolines and related analogs
GB9225859D0 (en) * 1992-12-11 1993-02-03 Smithkline Beecham Plc Novel treatment
US5356910A (en) * 1993-07-19 1994-10-18 Hoechst-Roussel Pharmaceuticals Inc. Use of N-(pyridinyl)-1H-indol-1-amines for the treatment of obsessive-compulsive disorder
GB0119435D0 (en) * 2001-02-15 2001-10-03 Aventis Pharm Prod Inc Method of treating of demyelinating diseases or conditions
EP1424325A4 (en) * 2001-09-07 2005-12-21 Ono Pharmaceutical Co INDOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICAMENTS CONTAINING THEM AS AN ACTIVE AGENT
GT200500063A (es) * 2004-04-01 2005-10-14 Metodo para tratar la esquizofrenia y/o anormalidades glucoregulatorias
CN105669540A (zh) 2009-01-28 2016-06-15 卡鲁斯治疗有限公司 Scriptaid电子等排体及其在治疗中的用途
NZ707366A (en) * 2012-11-07 2018-11-30 Karus Therapeutics Ltd Novel histone deacetylase inhibitors and their use in therapy
DK2994465T3 (en) 2013-05-10 2018-10-08 Karus Therapeutics Ltd HISTONDEACETYLASE INHIBITORS UNKNOWN
GB201419264D0 (en) 2014-10-29 2014-12-10 Karus Therapeutics Ltd Compounds
GB201419228D0 (en) 2014-10-29 2014-12-10 Karus Therapeutics Ltd Compounds
CA3104928A1 (en) 2018-08-13 2020-02-20 F. Hoffmann-La Roche Ag New heterocyclic compounds as monoacylglycerol lipase inhibitors
CR20220104A (es) 2019-09-12 2022-04-20 Hoffmann La Roche Compuestos de 4,4a,5,7,8,8a-hexapirido[4,3-b][1,4]oxazin-3-ona como inhibidores de magl

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4029657A (en) * 1976-06-14 1977-06-14 The Dow Chemical Company 6,7-Dichloro-3,4-dihydro-2H-pyrazino(2,3-B)(1,4)oxazines
DE2726437A1 (de) * 1977-06-11 1978-12-21 Bayer Ag Hydrazonfarbstoffe
US4880822A (en) * 1987-04-24 1989-11-14 Hoechst-Roussel Pharmaceuticals, Inc. N-(pyridinyl)-1H-indol-1-amines
US4970218A (en) * 1987-04-24 1990-11-13 Hoechst-Roussel Pharmaceuticals Inc. N-(pyridinyl)-1H-indol-1-amines
EP0287982B1 (en) * 1987-04-24 1994-12-07 Hoechst-Roussel Pharmaceuticals Incorporated N-(Pyridinyl)-1H-indol-1-amines, a process for their preparation and their use as medicaments
US5039811A (en) * 1987-04-24 1991-08-13 Hoechst-Roussel Pharmaceuticals Inc. Preparation of N-(pyridinyl)-1H-indol-1-amines
US4916135A (en) * 1989-05-08 1990-04-10 Hoechst Roussel Pharmaceuticals Inc. N-heteroaryl-4-quinolinamines
US5006537A (en) * 1989-08-02 1991-04-09 Hoechst-Roussel Pharmaceuticals, Inc. 1,3-dihydro-1-(pyridinylamino)-2H-indol-2-ones
EP0415103B1 (en) * 1989-08-02 1995-02-01 Hoechst-Roussel Pharmaceuticals Incorporated 2,3-Dihydro-1-(pyridinylamino)-indoles, a process for their preparation and their use as medicaments
US4983608A (en) * 1989-09-05 1991-01-08 Hoechst-Roussell Pharmaceuticals, Inc. N-substituted-4-pyrimidinamines and pyrimidinediamines

Also Published As

Publication number Publication date
JPH05112572A (ja) 1993-05-07
EP0509400B1 (en) 1996-07-03
NO921490L (no) 1992-10-16
PL294221A1 (en) 1993-08-09
IE74907B1 (en) 1997-08-13
HU9201290D0 (en) 1992-07-28
NO301765B1 (no) 1997-12-08
HUT62588A (en) 1993-05-28
ATE140006T1 (de) 1996-07-15
JP2608359B2 (ja) 1997-05-07
DE69211892T2 (de) 1996-12-19
NO921490D0 (no) 1992-04-14
DK0509400T3 (da) 1996-10-28
DE69211892D1 (de) 1996-08-08
NZ242309A (en) 1995-07-26
ES2094840T3 (es) 1997-02-01
IL101589A0 (en) 1992-12-30
AU1485292A (en) 1992-10-22
KR920019796A (ko) 1992-11-20
FI921641A (fi) 1992-10-16
US5276156A (en) 1994-01-04
US5519131A (en) 1996-05-21
NZ248131A (en) 1995-07-26
AU643135B2 (en) 1993-11-04
IE921190A1 (en) 1992-10-21
RU2042680C1 (ru) 1995-08-27
TW211016B (el) 1993-08-11
CA2065986C (en) 2006-02-21
EP0509400A1 (en) 1992-10-21
FI97544B (fi) 1996-09-30
CA2065986A1 (en) 1992-10-16
FI921641A0 (fi) 1992-04-13
PL168671B1 (pl) 1996-03-29
CS113592A3 (en) 1992-11-18
KR100201509B1 (ko) 1999-06-15
CZ282054B6 (cs) 1997-05-14
FI97544C (fi) 1997-01-10
ZA922721B (en) 1992-11-25
US5214038A (en) 1993-05-25
IL101589A (en) 1996-10-31

Similar Documents

Publication Publication Date Title
NZ235460A (en) Hexahydro-1,3a,8-trimethylpyrrolo(2,3-b)indol-5-yl-carbamate derivatives and pharmaceutical compositions
GR3020612T3 (en) 1-(Pyrido[3,4-b]-1,4-oxazinyl-4-yl)-1H-indoles, intermediates and a process for their preparation, and their use as medicaments
ES8801269A1 (es) Un procedimiento para preparar benzo(c)-1,5-naftiridinas
GR3031538T3 (en) Pyrido[3,4-b]pyrrolo[1,2-e][1,4,5]oxadiazepines and related analogs, a process for their preparation and their use as medicaments
ZA904442B (en) 4,5,5a,6-tetrahydro-3h-isoxazolo(5,4,3-kl)acridines derivatives,a process for their preparation and their use as medicaments